CAPITAL AND CODEINE (ACETAMINOPHEN; CODEINE PHOSPHATE) — FDA Approval ANDA085883 (ACTAVIS MID ATLANTIC)
CAPITAL AND CODEINE (ACETAMINOPHEN; CODEINE PHOSPHATE) — FDA Approval ANDA085883 (ACTAVIS MID ATLANTIC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CAPITAL AND CODEINE; Active ingredients: ACETAMINOPHEN; CODEINE PHOSPHATE; Application number: ANDA085883.
| Brand name | CAPITAL AND CODEINE |
|---|---|
| Active ingredients | ACETAMINOPHEN; CODEINE PHOSPHATE |
| Application number | ANDA085883 |
| Sponsor | ACTAVIS MID ATLANTIC |
| Dosage form | SUSPENSION |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19790108 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →